These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 32845743)

  • 1. Patient characteristics of insulin lispro 200 units/mL users in real world setting in Germany.
    Schloot NC; Perez-Nieves M; Sapin H; Kruppert S; Otto T; Corrigan SM; Piras de Oliveira C
    Curr Med Res Opin; 2020 Oct; 36(10):1611-1617. PubMed ID: 32845743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany.
    Chen J; Perez-Nieves M; Piras De Oliveira C; Spaepen E; Osumili B; Poon JL; Schloot N; Lara N; Garcia Alvarez L; Roset M
    Postgrad Med; 2020 Nov; 132(8):727-736. PubMed ID: 33108957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of Patients with Diabetes Treated with Insulin Lispro 200 U/ml: A Real-World Study from Spain.
    Rubio de Santos M; Artime E; Duque N; Díaz-Cerezo S; Spaepen E; Carreño Á; Fernández A
    Diabetes Ther; 2022 Jun; 13(6):1147-1160. PubMed ID: 35449431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satisfaction, Preference and Injection Habits of Switching to 200 Units/ml Insulin Lispro Pen from 100 Units/ml: A Patient Survey in Germany.
    Chen J; Williams P; Perez-Nieves M; Piras De Oliveira C; Spaepen E; Osumili B; Poon JL; Schloot NC; Thun B; Blüher M
    Diabetes Ther; 2021 Nov; 12(11):2939-2953. PubMed ID: 34542865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL.
    de la Peña A; Seger M; Soon D; Scott AJ; Reddy SR; Dobbins MA; Brown-Augsburger P; Linnebjerg H
    Clin Pharmacol Drug Dev; 2016 Jan; 5(1):69-75. PubMed ID: 27119580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence.
    Kaiserman K; Jung H; Benabbad I; Karges B; Polak M; Rosilio M
    Pediatr Diabetes; 2017 Mar; 18(2):81-94. PubMed ID: 27390032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline factors associated with better response to insulin lispro low mixture or insulin glargine: A post hoc analysis of the DURABLE study.
    Jia N; Kindracki Z; Rodriguez A
    Diabetes Res Clin Pract; 2018 Jan; 135():134-142. PubMed ID: 29155123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Insulin Lispro Protamine Suspension in Pregnancy.
    Lapolla A; Dalfrà MG; Romoli E; Bonomo M; Moghetti P
    Adv Ther; 2015 Oct; 32(10):888-905. PubMed ID: 26499176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.
    Derosa G; Franzetti I; Querci F; Romano D; D'Angelo A; Maffioli P
    Diabetes Obes Metab; 2015 Jun; 17(6):554-559. PubMed ID: 25694300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study.
    Takeishi S; Tsuboi H; Takekoshi S
    J Diabetes Investig; 2018 Jan; 9(1):91-99. PubMed ID: 28371461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14-day crossover treatment study in people with type 1 diabetes.
    Andersen G; Meiffren G; Lamers D; DeVries JH; Ranson A; Seroussi C; Alluis B; Gaudier M; Soula O; Heise T
    Diabetes Obes Metab; 2018 Nov; 20(11):2627-2632. PubMed ID: 29923294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin lispro protamine suspension in the treatment of patients with type 1 and type 2 diabetes mellitus: a systematic review of published data.
    Ceriello A; Cremasco F; Romoli E; Rossi A; Gentilella R
    Expert Opin Pharmacother; 2012 Feb; 13(2):255-81. PubMed ID: 22242803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Humalog® 200 U/ml KwikPen™].
    Scheen AJ
    Rev Med Liege; 2015 Oct; 70(10):527-31. PubMed ID: 26727843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lispro insulin in people with non-alcoholic liver cirrhosis and type 2 diabetes mellitus.
    Gentile S; Guarino G; Strollo F; Romano M; Genovese S; Masarone M; Ceriello A
    Diabetes Res Clin Pract; 2016 Mar; 113():179-86. PubMed ID: 26803356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conversion of fast insulin intensive therapy to lispro insulin in type I diabetes. Pharmacoeconomic analysis of cost-effectiveness].
    Costa Pinel B; Belmonte Serrano M; Páez Vives F; Sabaté Obiol A; Estopá Sánchez A; Borrás Borrás J
    Rev Clin Esp; 2001 Aug; 201(8):448-54. PubMed ID: 11599156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonality of Insulin Use in German Outpatients With Diabetes: A Retrospective Analysis.
    Kostev K; Gläser S; Jacob L
    J Diabetes Sci Technol; 2017 Sep; 11(5):996-1000. PubMed ID: 28420259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment persistence in the use of basal insulins in Poland and Germany
.
    Rathmann W; Czech M; Franek E; Kostev K
    Int J Clin Pharmacol Ther; 2017 Feb; 55(2):119-125. PubMed ID: 27879196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.